SculptPeptide Tirzepatide 20mg (Research Grade)

Product Description

This product features Tirzepatide (20mg), a widely studied dual-agonist peptide known for its action on both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors.

Offered by SculptPeptides, this formulation is provided as a high-purity lyophilized powder. It is engineered to meet the stringent requirements of laboratory research, specifically for investigating metabolic pathways, glucose regulation, and weight-related biochemical responses in controlled settings.

Key Features

Dual-Agonist Mechanism: Activates both GIP and GLP-1 pathways simultaneously.
Research Optimized: Synthesized for high stability and purity to ensure experimental reproducibility.
Concentration: Each vial contains 20mg of lyophilized peptide.
Application: Intended for in vitro or in vivo laboratory analysis.

Disclaimer: This product is intended strictly for research and laboratory use only. It is not for human or animal consumption, medical treatment, or diagnostic use. Handling should be restricted to qualified professionals using appropriate safety protocols.